5 Topic Commentaries

Does Mitral Regurgitation Mechanism Matter After M-TEER?

• 

  David S. Bach, MD, FACC

  Cardiology

  •

  University of Michigan Medical School

  Retrospective data suggest that M-TEER among patients with aSMR is associated with good procedural success and improvement in HF symptoms.

  Source
• 

  Kendra J. Grubb, MD, MHA, FACC

  Cardiothoracic Surgery

  •

  Emory University

  We have great outcomes after mitral valve surgery for primary, degenerative MR because the ventricle is normal and we fix the valve.

  Source
• 

  Vinod H. Thourani, MD, FACC

  Cardiac Surgery

  •

  Piedmont Heart Institute

  Patients considered at high to prohibitive risk for surgery should go for TEER, assuming they meet the criteria.

  Source
• 

  Raj R. Makkar, MD, FACC

  Interventional Cardiology

  •

  Cedars-Sinai Medical Center

  We know from the COAPT trial that TEER reduces rehospitalization and mortality.

  Source
• 

  Isida Byku, MD, FACC

  Interventional Cardiology

  •

  Emory University Hospital

  Most of the patients who walk through our door are not suitable for COAPT.

  Source